A detailed history of Howland Capital Management LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Howland Capital Management LLC holds 6,445 shares of NVO stock, worth $655,714. This represents 0.03% of its overall portfolio holdings.

Number of Shares
6,445
Previous 8,030 19.74%
Holding current value
$655,714
Previous $1.15 Million 33.07%
% of portfolio
0.03%
Previous 0.06%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$119.07 - $145.42 $188,725 - $230,490
-1,585 Reduced 19.74%
6,445 $767,000
Q1 2024

May 03, 2024

SELL
$102.11 - $135.92 $73,110 - $97,318
-716 Reduced 8.19%
8,030 $1.03 Million
Q3 2023

Oct 17, 2023

BUY
$90.94 - $199.54 $625,030 - $1.37 Million
6,873 Added 366.95%
8,746 $795,000
Q2 2023

Jul 28, 2023

SELL
$155.98 - $172.65 $15,597 - $17,265
-100 Reduced 5.07%
1,873 $303,000
Q1 2023

May 05, 2023

SELL
$132.34 - $159.14 $56,773 - $68,271
-429 Reduced 17.86%
1,973 $313,000
Q1 2022

Apr 27, 2022

BUY
$93.1 - $112.54 $18,620 - $22,508
200 Added 9.08%
2,402 $267,000
Q4 2021

Jan 26, 2022

BUY
$95.88 - $117.08 $4,985 - $6,088
52 Added 2.42%
2,202 $247,000
Q3 2021

Oct 25, 2021

BUY
$84.42 - $106.62 $181,503 - $229,233
2,150 New
2,150 $206,000
Q2 2019

Jul 17, 2019

SELL
$46.79 - $52.47 $266,703 - $299,079
-5,700 Closed
0 $0
Q1 2019

Apr 22, 2019

BUY
$46.36 - $52.63 $32,452 - $36,841
700 Added 14.0%
5,700 $298,000
Q1 2018

May 02, 2018

SELL
$48.49 - $58.14 $133,347 - $159,885
-2,750 Reduced 35.48%
5,000 $246,000
Q3 2017

Oct 30, 2017

BUY
$41.15 - $49.22 $318,912 - $381,455
7,750
7,750 $373,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $230B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Howland Capital Management LLC Portfolio

Follow Howland Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Howland Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Howland Capital Management LLC with notifications on news.